Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in SLE Patients With Corticosteroid Therapy and High LDL Cholesterol Level

NCT00866229 is registered in ClinicalTrials.gov with Ramathibodi Hospital as lead sponsor.

NCT NCT00866229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00866229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in SLE Patients With Corticosteroid Therapy and High LDL Cholesterol Level
Lead sponsor
Ramathibodi Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2008
Completion date
June 30, 2010
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high ldl cholesterol level, systemic lupus erythematosus